|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.74 USD | +2.89% |
|
+4.83% | +14.30% |
| 04:09pm | GE HealthCare Technologies Receives FDA Marketing Clearance for Portrait VSM Monitor | MT |
| Apr. 22 | Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services | MT |
On April 11, 2024, Nucleus RadioPharma, Inc. closed the transaction. The company has amended the terms of the transaction. The company has received $10,099,956 in its second and final tranche.
The company has now issued $66,099,956 in the transaction. The transaction included participation from 12 investors pursuant to exemption provided under regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| +14.32% | 39.35B | |
| +8.34% | 219B | |
| +6.35% | 183B | |
| +10.48% | 133B | |
| +24.26% | 108B | |
| +0.27% | 63.06B | |
| +12.03% | 52.02B | |
| +3.96% | 48.2B | |
| -0.12% | 40.37B | |
| +25.32% | 32.03B |
GE HEALTHCARE TECHNOLOGIES INC. 
